J Pediatr Infect Dis 2020; 15(03): 123-128
DOI: 10.1055/s-0039-1700955
Original Article
Georg Thieme Verlag KG Stuttgart · New York

Evaluation of Platelet Activity Markers in Prognostic Value of Children with Crimean-Congo Hemorrhagic Fever

Ahmet Sami Güven
1   Department of Pediatrics, Meram Medical Faculty, Necmettin Erbakan University, Konya, Turkey
,
Fatma Duksal
2   Department of Pediatrics, Meram Training and Research Hospital, Konya, Turkey
,
Özge Metin Akcan
3   Division of Pediatric Infectious Diseases, Department of Pediatrics, Meram Medical Faculty, Necmettin Erbakan University, Konya, Turkey
,
Utku Aygüneş
4   Division of Pediatric Hematology, Department of Pediatrics, Faculty of Medicine, Cumhuriyet University, Sivas, Turkey
,
Mehmet Burhan Oflaz
1   Department of Pediatrics, Meram Medical Faculty, Necmettin Erbakan University, Konya, Turkey
› Author Affiliations
Further Information

Publication History

15 August 2019

25 November 2019

Publication Date:
08 January 2020 (online)

Abstract

Objective The aim of this study is to investigate the prognostic value of platelet (PLT) activity markers in children with Crimean-Congo hemorrhagic fever (CCHF) and compare results with healthy controls.

Materials and Methods A total of 135 patients with CCHF and 100 healthy children were included in this retrospective study. Mean age was 12.4 ± 3.3 years in CCHF group, and 92 patients were male. We measured PLT count, mean platelet volume (MPV), platelet distribution width (PDW), and mean platelet mass (MPM) as PLT activity markers.

Results A statistically significant decrease in MPM and PLT, and significantly higher levels of PDW and activated partial thromboplastin time (aPTT) and no significant difference in MPV were observed in patients with CCHF compared with controls. Although there were no significant differences between the severe and nonsevere CCHF groups in term of MPV and PDW, the MPM value was significantly decreased in severe patients (p < 0.001). Furthermore, MPM values were inversely correlated with aPTT (r = −0.617, p = 0.015), and positively correlated with PLT (r = 0.703, p < 0.001) which are considered likely to be indicators of disease severity. Multivariate logistic regression analysis revealed MPM as an independent risk factor for severe disease.

Conclusion Our study demonstrated that MPM values were decreased in severe cases compared with nonsevere in children with CCHF. The MPM as an indicator of PLT activation at the time of diagnosis in children with CCHF can be used as a prognostic index for disease severity.

 
  • References

  • 1 Ergönül O. Crimean-Congo haemorrhagic fever. Lancet Infect Dis 2006; 6 (04) 203-214
  • 2 Whitehouse CA. Crimean-Congo hemorrhagic fever. Antiviral Res 2004; 64 (03) 145-160
  • 3 Yun SH, Sim EH, Goh RY, Park JI, Han JY. Platelet activation: the mechanisms and potential biomarkers. BioMed Res Int 2016; 2016: 9060143
  • 4 Chandrashekar V, Tarigopula A. Can platelet distribution width be used to predict the possibility of chronic myeloproliferative neoplasms?. Lab Med 2019; 50 (02) 174-179
  • 5 Vagdatli E, Gounari E, Lazaridou E, Katsibourlia E, Tsikopoulou F, Labrianou I. Platelet distribution width: a simple, practical and specific marker of activation of coagulation. Hippokratia 2010; 14 (01) 28-32
  • 6 Yazici S, Yazici M, Erer B. , et al. The platelet functions in patients with ankylosing spondylitis: anti-TNF-alpha therapy decreases the mean platelet volume and platelet mass. Platelets 2010; 21 (02) 126-131
  • 7 Park Y, Schoene N, Harris W. Mean platelet volume as an indicator of platelet activation: methodological issues. Platelets 2002; 13 (5-6): 301-306
  • 8 Martin JF, Trowbridge EA, Salmon G, Plumb J. The biological significance of platelet volume: its relationship to bleeding time, platelet thromboxane B2 production and megakaryocyte nuclear DNA concentration. Thromb Res 1983; 32 (05) 443-460
  • 9 Burt FJ, Swanepoel R, Shieh WJ. , et al. Immunohistochemical and in situ localization of Crimean-Congo hemorrhagic fever (CCHF) virus in human tissues and implications for CCHF pathogenesis. Arch Pathol Lab Med 1997; 121 (08) 839-846
  • 10 Engin A, Yilmaz MB, Elaldi N. , et al. Crimean-Congo hemorrhagic fever: does it involve the heart?. Int J Infect Dis 2009; 13 (03) 369-373
  • 11 Ekiz F, Gürbüz Y, Basar Ö. , et al. Mean platelet volume in the diagnosis and prognosis of Crimean-Congo hemorrhagic fever. Clin Appl Thromb Hemost 2013; 19 (04) 441-444
  • 12 Yilmaz H, Yilmaz G, Menteşe A, Kostakoğlu U, Karahan SC, Köksal İ. Prognostic impact of platelet distribution width in patients with Crimean-Congo hemorrhagic fever. J Med Virol 2016; 88 (11) 1862-1866
  • 13 Ozkurt Z, Kiki I, Erol S. , et al. Crimean-Congo hemorrhagic fever in Eastern Turkey: clinical features, risk factors and efficacy of ribavirin therapy. J Infect 2006; 52 (03) 207-215
  • 14 Yilmaz GR, Buzgan T, Irmak H. , et al. The epidemiology of Crimean-Congo hemorrhagic fever in Turkey, 2002-2007. Int J Infect Dis 2009; 13 (03) 380-386
  • 15 Cevik MA, Erbay A, Bodur H. , et al. Clinical and laboratory features of Crimean-Congo hemorrhagic fever: predictors of fatality. Int J Infect Dis 2008; 12 (04) 374-379
  • 16 Amraotkar AR, Song DD, Otero D. , et al. Platelet count and mean platelet volume at the time of and after acute myocardial infarction. Clin Appl Thromb Hemost 2017; 23 (08) 1052-1059
  • 17 Nam M, Son BH, Seo JE, Kim IR, Park CK, Kim HK. Improved diagnostic and prognostic power of combined delta neutrophil index and mean platelet volume in pediatric sepsis. Ann Clin Lab Sci 2018; 48 (02) 223-230
  • 18 Bowles KM, Warner BA, Baglin TP. Platelet mass has prognostic value in patients with myelodysplastic syndromes. Br J Haematol 2006; 135 (02) 198-200
  • 19 Zisk JL, Mackley A, Christensen RD, Paul DA. Is a small platelet mass associated with intraventricular hemorrhage in very low-birth-weight infants?. J Perinatol 2011; 31 (12) 776-779
  • 20 Swanepoel R, Gill DE, Shepherd AJ, Leman PA, Mynhardt JH, Harvey S. The clinical pathology of Crimean-Congo hemorrhagic fever. Rev Infect Dis 1989; 11 (Suppl. 04) S794-S800
  • 21 Gasparyan AY, Ayvazyan L, Mikhailidis DP, Kitas GD. Mean platelet volume: a link between thrombosis and inflammation?. Curr Pharm Des 2011; 17 (01) 47-58
  • 22 Gawaz M, Langer H, May AE. Platelets in inflammation and atherogenesis. J Clin Invest 2005; 115 (12) 3378-3384
  • 23 Karpatkin S. Heterogeneity of human platelets. II. Functional evidence suggestive of young and old platelets. J Clin Invest 1969; 48 (06) 1083-1087
  • 24 Kaser A, Brandacher G, Steurer W. , et al. Interleukin-6 stimulates thrombopoiesis through thrombopoietin: role in inflammatory thrombocytosis. Blood 2001; 98 (09) 2720-2725
  • 25 Thompson CB, Eaton KA, Princiotta SM, Rushin CA, Valeri CR. Size dependent platelet subpopulations: relationship of platelet volume to ultrastructure, enzymatic activity, and function. Br J Haematol 1982; 50 (03) 509-519
  • 26 Karti SS, Odabasi Z, Korten V. , et al. Crimean-Congo hemorrhagic fever in Turkey. Emerg Infect Dis 2004; 10 (08) 1379-1384
  • 27 Schnittler HJ, Feldmann H. Viral hemorrhagic fever--a vascular disease?. Thromb Haemost 2003; 89 (06) 967-972